Literature DB >> 21437353

Imaging fibrin formation and platelet and endothelial cell activation in vivo.

L Bellido-Martín1, V Chen, R Jasuja, B Furie, B C Furie.   

Abstract

Over the past six decades research employing in vitro assays has identified enzymes, cofactors, cell receptors and associated ligands important to the haemostatic process and its regulation. These studies have greatly advanced our understanding of the molecular and cellular bases of haemostasis and thrombosis. However, in vitro assays cannot simultaneously reproduce the interactions of all of the components of the haemostatic process that occur in vivo nor do they reflect the importance of haemodynamic factors resulting from blood flow. To overcome these limitations investigators have increasingly turned to animal models of haemostasis and thrombosis. In this article we describe some advances in the visualisation of platelet and endothelial cell activation and blood coagulation in vivo and review what we have learned from our intravital microscopy experiments using primarily the laser-induced injury model for thrombosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21437353     DOI: 10.1160/TH10-12-0771

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  A systems approach to hemostasis: 4. How hemostatic thrombi limit the loss of plasma-borne molecules from the microvasculature.

Authors:  John D Welsh; Ryan W Muthard; Timothy J Stalker; Joshua P Taliaferro; Scott L Diamond; Lawrence F Brass
Journal:  Blood       Date:  2016-01-06       Impact factor: 22.113

2.  A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity.

Authors:  Timothy J Stalker; John D Welsh; Maurizio Tomaiuolo; Jie Wu; Thomas V Colace; Scott L Diamond; Lawrence F Brass
Journal:  Blood       Date:  2014-06-20       Impact factor: 22.113

3.  The hydraulic permeability of blood clots as a function of fibrin and platelet density.

Authors:  A R Wufsus; N E Macera; K B Neeves
Journal:  Biophys J       Date:  2013-04-16       Impact factor: 4.033

4.  Role of electrostatic interactions in binding of thrombin to the fibrinogen γ' chain.

Authors:  Kristine S Alexander; Michael G Fried; David H Farrell
Journal:  Biochemistry       Date:  2012-04-15       Impact factor: 3.162

5.  Mechanical vessel injury in zebrafish embryos.

Authors:  Hilary Clay; Shaun R Coughlin
Journal:  J Vis Exp       Date:  2015-02-17       Impact factor: 1.355

6.  Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?

Authors:  Jan David Hohmann; Xiaowei Wang; Stefanie Krajewski; Carly Selan; Carolyn A Haller; Andreas Straub; Elliot L Chaikof; Harshal H Nandurkar; Christoph E Hagemeyer; Karlheinz Peter
Journal:  Blood       Date:  2013-02-04       Impact factor: 22.113

Review 7.  Harnessing the platelet signaling network to produce an optimal hemostatic response.

Authors:  Lawrence F Brass; Maurizio Tomaiuolo; Timothy J Stalker
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-11       Impact factor: 3.722

Review 8.  Platelet signaling.

Authors:  Timothy J Stalker; Debra K Newman; Peisong Ma; Kenneth M Wannemacher; Lawrence F Brass
Journal:  Handb Exp Pharmacol       Date:  2012

9.  Platelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis.

Authors:  Donny Hanjaya-Putra; Carolyn Haller; Xiaowei Wang; Erbin Dai; Bock Lim; Liying Liu; Patrick Jaminet; Joy Yao; Amy Searle; Thomas Bonnard; Christoph E Hagemeyer; Karlheinz Peter; Elliot L Chaikof
Journal:  JCI Insight       Date:  2018-08-09

10.  Quercetin-3-rutinoside Inhibits Protein Disulfide Isomerase by Binding to Its b'x Domain.

Authors:  Lin Lin; Srila Gopal; Anish Sharda; Freda Passam; Sheryl R Bowley; Jack Stopa; Guangpu Xue; Cai Yuan; Barbara C Furie; Robert Flaumenhaft; Mingdong Huang; Bruce Furie
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.